REQUEST A DEMO
Total
USD $0.00
Search more companies

Novugen Oncology Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Full name: Novugen Oncology Sdn. Bhd. Profile Updated: January 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Novugen Oncology Sdn. Bhd. is an enterprise based in Malaysia. Its main office is in Shah Alam. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on July 12, 2026. There was a net sales revenue increase of 26.66% reported in Novugen Oncology Sdn. Bhd.’s latest financial highlights for 2024. There was a total negative growth of 11.41% in Novugen Oncology Sdn. Bhd.’s total assets over the same period. The enterprise’s net profit margin decreased by 16.3% in 2024.

Headquarters
No.3, Jalan Jururancang U1/21, Hicom Glenmarie Industrial Park
Shah Alam; Selangor; Postal Code: 40150

Contact Details: Purchase the Novugen Oncology Sdn. Bhd. report to view the information.

Website: http://www.novugen.com

Basic Information
Financial Auditors:
Purchase the Novugen Oncology Sdn. Bhd. report to view the information.
Incorporation Date:
July 12, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novugen Oncology Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
26.66%
Total Operating Revenue
26.66%
Operating Profit
-190.22%
EBITDA
N/A
Net Profit/Loss for the Period
-185.75%
Total Assets
-11.41%
Total Equity
-8.67%
Operating Profit Margin
-16.5%
Net Profit Margin
-16.3%
Return on Equity (ROE)
-6.46%
Debt / Equity
-0.11%
Quick Ratio
1.55%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?